Browsing Patents by Subject "G01N 2500/00 (20130101)"
Now showing items 1-1 of 1
-
Engineered respiratory syncytial viruses with control of cell-to-cell virus transmission for enhanced safety of live virus vaccines
(U.S. Patent and Trademark Office, 2020-11-24)Highly antigenic yet safe vaccines against diseases caused by Paramyxoviridae viruses such as respiratory syncytial virus (RSV) are provided. The vaccines comprise attenuated Paramyxoviridae viruses with high antigenicity ...